MWB Consulting offers drug development, drug safety and regulatory affairs consulting services to the international pharmaceutical industry. We provide experienced, effective consultation for clients who need access to an extensive knowledge base and to drug development experience to avoid costly pitfalls and save time to develop and bring new drugs to market.

Our expertise is focused on the late non-clinical to regulatory approval processes of drug development and is paired with a unique combination of competency in both US and EU clinical and regulatory environments. Our therapeutic strengths are broad and include CNS, oncology, endocrinology, GI, anti-infectives and biotechnology.

The success of MWB Consulting is predicated on our ability to exceed expectations on every project.